Header Logo

Lucia Hans

Concepts (68)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV-1
10
2024
1260
2.320
 Why?
HIV Infections
14
2024
5097
1.850
 Why?
Anti-HIV Agents
5
2023
1324
1.490
 Why?
Dried Blood Spot Testing
4
2021
24
1.260
 Why?
HIV-2
2
2021
15
0.930
 Why?
HIV Integrase Inhibitors
1
2022
33
0.800
 Why?
Pyridones
4
2023
100
0.760
 Why?
Nucleic Acid Amplification Techniques
1
2021
35
0.740
 Why?
Viral Load
8
2024
819
0.570
 Why?
Humans
16
2024
14537
0.550
 Why?
Sensitivity and Specificity
6
2024
385
0.510
 Why?
RNA, Viral
5
2024
303
0.460
 Why?
Piperazines
2
2022
82
0.390
 Why?
Oxazines
2
2022
81
0.390
 Why?
Heterocyclic Compounds, 3-Ring
2
2022
85
0.390
 Why?
Retrospective Studies
3
2022
799
0.350
 Why?
Specimen Handling
2
2021
105
0.320
 Why?
South Africa
6
2024
7596
0.240
 Why?
Rilpivirine
1
2023
7
0.210
 Why?
Mutation
2
2021
306
0.210
 Why?
Drug Resistance, Viral
2
2021
278
0.200
 Why?
Protease Inhibitors
1
2022
23
0.200
 Why?
Zidovudine
1
2022
59
0.200
 Why?
Lamivudine
1
2022
89
0.200
 Why?
Reverse Transcriptase Inhibitors
1
2022
118
0.190
 Why?
Tenofovir
1
2022
171
0.190
 Why?
Triazoles
1
2021
20
0.190
 Why?
Early Diagnosis
1
2021
82
0.180
 Why?
Laboratories
1
2021
47
0.180
 Why?
Treatment Failure
1
2021
175
0.180
 Why?
Developing Countries
1
2023
400
0.170
 Why?
Child
2
2024
2242
0.170
 Why?
Plasma
1
2019
39
0.160
 Why?
Tuberculosis
1
2024
543
0.160
 Why?
Pandemics
1
2021
296
0.160
 Why?
Anti-Retroviral Agents
1
2023
551
0.150
 Why?
Infant, Newborn, Diseases
1
2017
73
0.140
 Why?
Adolescent
1
2022
2985
0.120
 Why?
Viremia
2
2023
66
0.100
 Why?
Molecular Diagnostic Techniques
2
2024
132
0.100
 Why?
Limit of Detection
2
2020
14
0.080
 Why?
Cohort Studies
2
2021
967
0.070
 Why?
Adult
3
2024
5913
0.070
 Why?
Quality-Adjusted Life Years
1
2024
34
0.060
 Why?
Edetic Acid
1
2024
8
0.060
 Why?
Reproducibility of Results
1
2024
217
0.050
 Why?
Cost-Benefit Analysis
1
2024
253
0.050
 Why?
Communicable Disease Control
1
2023
101
0.050
 Why?
Biological Assay
1
2021
32
0.050
 Why?
Drug Resistance
1
2021
35
0.050
 Why?
Reagent Kits, Diagnostic
1
2021
56
0.050
 Why?
Feasibility Studies
1
2021
101
0.050
 Why?
Genotype
1
2021
442
0.040
 Why?
Point-of-Care Systems
1
2020
91
0.040
 Why?
Paper
1
2019
2
0.040
 Why?
Filtration
1
2019
3
0.040
 Why?
Blood Specimen Collection
1
2019
13
0.040
 Why?
Cross-Sectional Studies
1
2024
1422
0.040
 Why?
Temperature
1
2019
56
0.040
 Why?
Female
2
2024
9103
0.040
 Why?
Neonatal Screening
1
2017
24
0.040
 Why?
Lost to Follow-Up
1
2017
62
0.030
 Why?
Polymerase Chain Reaction
1
2017
260
0.030
 Why?
Infectious Disease Transmission, Vertical
1
2017
472
0.030
 Why?
Prevalence
1
2017
1192
0.030
 Why?
Infant, Newborn
1
2017
1479
0.030
 Why?
Infant
1
2017
2244
0.020
 Why?
Male
1
2017
6754
0.020
 Why?
Hans's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (68)
Explore
_
Co-Authors (15)
Explore
_
Similar People (60)
Explore
_